LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹21 Cr | ₹13 Cr | ₹12 Cr | ₹-47 Cr | ₹-21 Cr |
What is the latest Net Current Assets ratio of LYKA LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹-47 Cr |
| Mar2021 | ₹-21 Cr |
How is Net Current Assets of LYKA LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | 61.49 | |
| Mar2024 | ₹13 Cr | 10.99 | |
| Mar2023 | ₹12 Cr | Positive | |
| Mar2022 | ₹-47 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Net Current Assets of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹289.3 Cr | 6.6% | 3.5% | -47.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,319.0 Cr | 2.4% | -2.5% | -7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,383.0 Cr | 3.9% | 2.6% | 3.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,241.0 Cr | 2.5% | 4.1% | 12.3% | Stock Analytics | |
| CIPLA | ₹123,617.0 Cr | 1.3% | 0.6% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,825.0 Cr | -1.2% | -1.5% | -9.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 6.6% |
3.5% |
-47.6% |
| SENSEX | 0.5% |
-0.2% |
8.4% |
You may also like the below Video Courses